Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Leading Change in Academic Pharmacy: Report of the 2018-2019 AACP Academic Affairs Committee.

Gregory DF, Boje KM, Carter RA, Daugherty KK, Hagemeier NE, Munger MA, Umland EM, Wagner JL.

Am J Pharm Educ. 2019 Dec;83(10):7661. doi: 10.5688/ajpe7661.

2.

Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study.

Ventricelli DJ, Mathis SM, Foster KN, Pack RP, Tudiver F, Hagemeier NE.

Subst Use Misuse. 2020;55(3):349-357. doi: 10.1080/10826084.2019.1670210. Epub 2019 Oct 8.

PMID:
31591924
3.

Explaining Pharmacy Students' Dispensing Intentions in Substance Abuse-Related Gray Areas Using the Theory of Planned Behavior.

Dowling-McClay K, Mospan CM, Subedi P, Hagemeier NE.

Am J Pharm Educ. 2019 Jun;83(5):6767. doi: 10.5688/ajpe6767.

4.

Revisiting Faculty Citizenship.

Hammer DP, Bynum LA, Carter J, Hagemeier NE, Kennedy DR, Khansari P, Stamm P, Crabtree B.

Am J Pharm Educ. 2019 May;83(4):7378. doi: 10.5688/ajpe7378.

5.

Student Pharmacists' Personal Finance Perceptions, Projected Indebtedness Upon Graduation, and Career Decision-making.

Hagemeier NE, Gentry CK, Byrd DC, Cross LB, Rose D, Ansari N, Subedi P, Branham T.

Am J Pharm Educ. 2019 May;83(4):6722. doi: 10.5688/ajpe6722.

6.

Breaking Down Barriers to Pharmacy Graduate Education: The Report of the 2017-2018 Research and Graduate Affairs Committee.

Poloyac SM, Cavanaugh JE, Hagemeier NE, Kumar K, Melchert RB, O'Donnell JM, Priefer R, Touchette DR, Farrell DF, Block KF.

Am J Pharm Educ. 2018 Sep;82(7):7147. doi: 10.5688/ajpe7147.

7.
8.

Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?

Salwan AJ, Hagemeier NE, Harirforoosh S.

Clin Drug Investig. 2018 Jul;38(7):573-577. doi: 10.1007/s40261-018-0651-3. Review.

PMID:
29651781
9.

Pharmacists' and prescribers' neonatal abstinence syndrome (NAS) prevention behaviors: a preliminary analysis.

Hagemeier NE, Click IA, Flippin H, Gilliam H, Ross A, Basden JA, Carico R Jr.

Int J Clin Pharm. 2018 Feb;40(1):20-25. doi: 10.1007/s11096-017-0573-9. Epub 2017 Dec 5.

PMID:
29209864
10.

Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.

Hagemeier NE, Tudiver F, Brewster S, Hagy EJ, Ratliff B, Hagaman A, Pack RP.

Subst Abus. 2018 Jan 2;39(1):89-94. doi: 10.1080/08897077.2017.1365803. Epub 2017 Sep 15.

11.

Assessing Faculty and Student Interpretations of AACP Survey Items with Cognitive Interviewing.

Karpen SC, Hagemeier NE.

Am J Pharm Educ. 2017 Jun;81(5):88. doi: 10.5688/ajpe81588.

12.

Interprofessional Research, Training and Outreach: The ETSU Prescription Drug Abuse/Misuse Working Group.

Pack RP, Hagaman A, Warfield S, Gray JA, Tudiver F, Alamian A, Hagemeier NE.

Int J Health Sci Educ. 2016 Aug;3(2). pii: 5. No abstract available.

13.

Situational communication self-confidence among community pharmacists: A descriptive analysis.

Hagemeier NE, Ventricelli D, Sevak RJ.

Res Social Adm Pharm. 2017 Nov;13(6):1175-1180. doi: 10.1016/j.sapharm.2016.12.003. Epub 2016 Dec 18. No abstract available.

14.

Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.

Hagemeier NE, Tudiver F, Brewster S, Hagy EJ, Hagaman A, Pack RP.

Res Social Adm Pharm. 2016 Nov - Dec;12(6):937-948. doi: 10.1016/j.sapharm.2015.12.008. Epub 2015 Dec 29.

15.

Teaching Communication Skills to Medical and Pharmacy Students Through a Blended Learning Course.

Hess R, Hagemeier NE, Blackwelder R, Rose D, Ansari N, Branham T.

Am J Pharm Educ. 2016 May 25;80(4):64. doi: 10.5688/ajpe80464.

16.

Fellowships in community pharmacy research: Experiences of five schools and colleges of pharmacy.

Snyder ME, Frail CK, Gernant SA, Bacci JL, Coley KC, Colip LM, Ferreri SP, Hagemeier NE, McGivney MS, Rodis JL, Smith MG, Smith RB.

J Am Pharm Assoc (2003). 2016 May-Jun;56(3):316-22. doi: 10.1016/j.japh.2015.11.015. Epub 2016 Apr 12.

17.

Student Performance in a Pharmacotherapy Oncology Module Before and After Flipping the Classroom.

Bossaer JB, Panus P, Stewart DW, Hagemeier NE, George J.

Am J Pharm Educ. 2016 Mar 25;80(2):31. doi: 10.5688/ajpe80231.

18.

Correlates of Prescription Opioid Legitimacy Judgments Among Community Pharmacists.

Hagemeier NE, Alamian A, Murawski MM, Flippin H, Hagy EJ, Pack RP.

Subst Use Misuse. 2016 May 11;51(6):692-9. doi: 10.3109/10826084.2015.1135952. Epub 2016 Apr 12.

PMID:
27070040
19.

A Subgroup Analysis of the Impact of Self-testing Frequency on Examination Scores in a Pathophysiology Course.

Panus PC, Stewart DW, Hagemeier NE, Thigpen JC, Brooks L.

Am J Pharm Educ. 2014 Nov 15;78(9):165. doi: 10.5688/ajpe789165.

20.

Impact of an interprofessional communication course on nursing, medical, and pharmacy students' communication skill self-efficacy beliefs.

Hagemeier NE, Hess R Jr, Hagen KS, Sorah EL.

Am J Pharm Educ. 2014 Dec 15;78(10):186. doi: 10.5688/ajpe7810186.

21.

Factors associated with provision of addiction treatment information by community pharmacists.

Hagemeier NE, Alamian A, Murawski MM, Pack RP.

J Subst Abuse Treat. 2015 May;52:67-72. doi: 10.1016/j.jsat.2014.11.006. Epub 2014 Nov 21.

PMID:
25491734
22.

An instrument to assess subjective task value beliefs regarding the decision to pursue postgraduate training.

Hagemeier NE, Murawski MM.

Am J Pharm Educ. 2014 Feb 12;78(1):11. doi: 10.5688/ajpe78111.

23.

Theoretical exploration of Tennessee community pharmacists' perceptions regarding opioid pain reliever abuse communication.

Hagemeier NE, Murawski MM, Lopez NC, Alamian A, Pack RP.

Res Social Adm Pharm. 2014 May-Jun;10(3):562-75. doi: 10.1016/j.sapharm.2013.07.004. Epub 2013 Aug 24.

PMID:
23981913
24.

The influence of faculty mentors on junior pharmacy faculty members' career decisions.

Hagemeier NE, Murawski MM, Popovich NG.

Am J Pharm Educ. 2013 Apr 12;77(3):51. doi: 10.5688/ajpe77351.

25.

Prescription drug abuse: a comparison of prescriber and pharmacist perspectives.

Hagemeier NE, Gray JA, Pack RP.

Subst Use Misuse. 2013 Jun;48(9):761-8. doi: 10.3109/10826084.2013.787101. Epub 2013 Apr 22.

PMID:
23607672
26.

Prescription drug abuse and DEA-sanctioned drug take-back events: characteristics and outcomes in rural Appalachia.

Gray JA, Hagemeier NE.

Arch Intern Med. 2012 Aug 13;172(15):1186-7. doi: 10.1001/archinternmed.2012.2374. No abstract available.

PMID:
22733245
27.
28.

A curriculum development simulation in a graduate program.

Newton GD, Hagemeier NE.

Am J Pharm Educ. 2011 Nov 10;75(9):184. doi: 10.5688/ajpe759184.

29.

Interprofessional awareness: a case study.

Hagemeier NE, Hagemeier MA.

J Am Pharm Assoc (2003). 2011 Jul-Aug;51(4):455-6. doi: 10.1331/JAPhA.2011.10140. No abstract available.

PMID:
21752765
30.

Student pharmacists' perceptions of testing and study strategies.

Hagemeier NE, Mason HL.

Am J Pharm Educ. 2011 Mar 10;75(2):35.

31.

Economic analysis of earning a PhD degree after completion of a PharmD degree.

Hagemeier NE, Murawski MM.

Am J Pharm Educ. 2011 Feb 10;75(1):15.

32.

A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites.

Bernsen HJ, Rijken PF, Hagemeier NE, van der Kogel AJ.

Microvasc Res. 1999 May;57(3):244-57.

PMID:
10329251
33.

Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy.

van Geel IP, Oppelaar H, Rijken PF, Bernsen HJ, Hagemeier NE, van der Kogel AJ, Hodgkiss RJ, Stewart FA.

Br J Cancer. 1996 Feb;73(3):288-93.

Supplemental Content

Loading ...
Support Center